- 983.907
- +0.663+0.07%
U.S. Drug Shortages Worsen to Reach a Decade High: Report
FDA Grants Expanded Approval for Amgen's Blincyto in ALL
Pfizer Stock Traded in the Red for Seven Straight Days
EU to Require Additional Cancer Risk Labeling on CAR T Therapies
What 8 Analyst Ratings Have To Say About Gilead Sciences
In the last three months, 8 analysts have published ratings on Gilead Sciences (NASDAQ:GILD), offering a diverse range of perspectives from bullish to bearish.The table below provides a snapshot of th
How Is The Market Feeling About Pfizer?
Pfizer's (NYSE:PFE) short percent of float has risen 8.06% since its last report. The company recently reported that it has 75.97 million shares sold short, which is 1.34% of all regular shares that a
Gilead Spikes as Jefferies Highlights Weight Loss Prospects
CDC 'Preparing for the Possibility' Bird Flu Could Spread More Easily
Amgen Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/14/2024 11.78% RBC Capital $328 → $332 Maintains Outperform 05/09/2024 -20.88% Mizuho $223 → $235 Maint
Pfizer's Elrexfio Buoyed by Multiple Myeloma Survival Data
Pfizer's ELREXFIO Shows Median Overall Survival Of More Than Two Years In Phase 2 MagnetisMM-3 Study
Patients in MagnetisMM-3 demonstrated a median overall survival (OS) of 24.6 months, with median progression-free survival (PFS) of 17.2 monthsPfizer Inc. (NYSE:PFE) today announced detailed overall s
FDA Recommends KP.2 Strain Be Used in Updated COVID-19 Shots
Nasdaq 100, S&P 500 Close At Record Highs As Tech Stocks Reclaim Dominance: Thursday's Gainers & Losers
The Nasdaq 100 index posted its fourth consecutive session in the green on Thursday, closing up 0.6% at 19,576 points and reaching new all-time highs as tech stocks drive broader market gains.The S&P
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
How Is The Market Feeling About Johnson & Johnson?
Johnson & Johnson's (NYSE:JNJ) short percent of float has risen 15.28% since its last report. The company recently reported that it has 19.93 million shares sold short, which is 0.83% of all regular s
What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower
Pfizer Inc. (NYSE:PFE) shares are ticking lower after the company disclosed disappointing results from its Phase 3 CIFFREO study, evaluating the investigational gene therapy for Duchenne muscular dyst
4 Stocks to Watch on Thursday: ADBE, KMB and More
Sarepta Gains After Pfizer's Late-stage Setback for Duchenne Therapy
Decoding Amgen's Options Activity: What's the Big Picture?
High-rolling investors have positioned themselves bullish on Amgen (NASDAQ:AMGN), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's track
Cancer Victims Seek Court Order to Block J&J's Bankruptcy Bid